Israel Englander Ironwood Pharmaceuticals Inc Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Millennium Management LLC holds 1,328,760 shares of IRWD stock, worth $5.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,328,760

Previous 461,444 187.96%

Holding current value

$5.71 Million

Previous $4.02 Million 115.55%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$5.58 - $8.61 $4.84 Million - $7.47 Million	867,316 Added 187.96%	1,328,760 $8.66 Million
Q1 2024 May 15, 2024	SELL	$8.32 - $15.45 $4.25 Million - $7.89 Million	-510,691 Reduced 52.53%	461,444 $4.02 Million
Q4 2023 Feb 14, 2024	BUY	$8.79 - $11.51 $6.3 Million - $8.25 Million	717,066 Added 281.13%	972,135 $11.1 Million
Q2 2023 Aug 14, 2023	SELL	$10.1 - $11.6 $11.4 Million - $13.1 Million	-1,127,479 Reduced 81.55%	255,069 $2.71 Million
Q1 2023 May 15, 2023	SELL	$10.37 - $12.56 $27 Million - $32.7 Million	-2,607,394 Reduced 65.35%	1,382,548 $14.5 Million
Q4 2022 Feb 14, 2023	BUY	$9.9 - $12.43 $21.6 Million - $27.2 Million	2,184,767 Added 121.03%	3,989,942 $49.4 Million
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $7.34 Million - $8.97 Million	724,203 Added 67.0%	1,805,175 $18.7 Million
Q2 2022 Aug 15, 2022	BUY	$11.05 - $12.72 $318,880 - $367,073	28,858 Added 2.74%	1,080,972 $12.5 Million
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $5.71 Million - $6.93 Million	-537,702 Reduced 33.82%	1,052,114 $13.2 Million
Q4 2021 Feb 14, 2022	BUY	$10.86 - $13.95 $481,467 - $618,459	44,334 Added 2.87%	1,589,816 $18.5 Million
Q3 2021 Nov 15, 2021	SELL	$11.92 - $13.92 $2.54 Million - $2.97 Million	-213,471 Reduced 12.14%	1,545,482 $20.2 Million
Q2 2021 Aug 16, 2021	BUY	$10.16 - $13.11 $7.88 Million - $10.2 Million	775,496 Added 78.85%	1,758,953 $22.6 Million
Q1 2021 May 17, 2021	BUY	$9.04 - $11.86 $1.14 Million - $1.5 Million	126,422 Added 14.75%	983,457 $11 Million
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $7.05 Million - $9.5 Million	778,749 Added 994.75%	857,035 $9.76 Million
Q3 2020 Nov 16, 2020	SELL	$8.99 - $10.74 $2.09 Million - $2.49 Million	-232,012 Reduced 74.77%	78,286 $704,000
Q2 2020 Aug 14, 2020	BUY	$9.14 - $11.97 $2.62 Million - $3.43 Million	286,318 Added 1193.99%	310,298 $3.2 Million
Q1 2020 May 14, 2020	SELL	$8.58 - $14.01 $5.53 Million - $9.04 Million	-644,937 Reduced 96.42%	23,980 $242,000
Q4 2019 Feb 14, 2020	SELL	$8.22 - $14.0 $2.98 Million - $5.07 Million	-362,381 Reduced 35.14%	668,917 $8.9 Million
Q3 2019 Nov 14, 2019	BUY	$8.59 - $10.96 $5.58 Million - $7.12 Million	649,831 Added 170.35%	1,031,298 $8.85 Million
Q2 2019 Aug 15, 2019	BUY	$9.8 - $12.89 $3.57 Million - $4.69 Million	363,821 Added 2061.78%	381,467 $4.17 Million
Q2 2019 Aug 14, 2019	SELL	$9.8 - $12.89 $8.33 Million - $11 Million	-850,412 Reduced 97.97%	17,646 $242,000
Q1 2019 May 14, 2019	SELL	$8.27 - $12.73 $4.18 Million - $6.43 Million	-505,022 Reduced 36.78%	868,058 $11.7 Million
Q4 2018 Feb 14, 2019	BUY	$7.8 - $16.13 $8.67 Million - $17.9 Million	1,111,814 Added 425.55%	1,373,080 $14.2 Million
Q3 2018 Nov 14, 2018	BUY	$14.31 - $17.65 $2.78 Million - $3.42 Million	193,961 Added 288.18%	261,266 $4.82 Million
Q2 2018 Aug 14, 2018	BUY	$11.83 - $16.2 $796,218 - $1.09 Million	67,305 New	67,305 $1.29 Million
Q1 2018 May 15, 2018	SELL	$11.13 - $13.63 $272,295 - $333,457	-24,465 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$12.16 - $14.58 $297,494 - $356,699	24,465	24,465 $367,000

Others Institutions Holding IRWD

# of Institutions

247

Shares Held

171M

Call Options Held

11.2M

Put Options Held

28.5K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $659M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account